Autologous adipose tissue-derived stem cell injections (AASCIs) are a growing trend in the United States.1 Although recent advances with the transplantation of stem cells for Stargardt disease and age-related macular degeneration has spurred promise for future vision-saving therapy, a concurrent surge in for-profit “stem cell” clinics have arisen.1,2 In 2017, Kuriyan et al3 reported the cases of 3 patients who were diagnosed as having traction retinal detachments after AASCI treatment for age-related macular degeneration. Here, we report a similar complication at a different clinic of a patient after receiving intravitreal AASCIs for retinitis pigmentosa, supporting the wider prevalence of such complications.
Rong AJ, Lam BL, Ansari ZA, Albini TA. Vision Loss Secondary to Autologous Adipose Stem Cell Injections: A Rising Problem. JAMA Ophthalmol. 2018;136(1):97–99. doi:10.1001/jamaophthalmol.2017.5453
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: